525. Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years

BACKGROUND: Molnupiravir is being widely used as a treatment for coronavirus disease 2019 (COVID-19); however, its acceptability and safety in older patients aged ≥ 80 years in real-world clinical practice is not well understood. METHODS: We conducted a single-centre retrospective study and assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kohei, Kanai, Osamu, Hata, Hiroaki, Odagaki, Takao, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678566/
http://dx.doi.org/10.1093/ofid/ofad500.594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678566/
http://dx.doi.org/10.1093/ofid/ofad500.594

Ejemplares similares